Angiomyolipoma diagnostic study of choice
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2], Rekha, M.D.
Overview
There is no single diagnostic study of choice for the diagnosis of angiomyolipoma, but angiomyolipoma can be diagnosed based on imaging studies and percutaneous biopsies depending upon the fat content of the lesion, hemorrhage, calcification or necrosis.
Diagnostic Study of Choice
Study of choice
- There is no single diagnostic study of choice for the diagnosis of angiomyolipoma.
- Angiomyolipoma can be diagnosed based on imaging studies and percutaneous biopsies depending upon the following:[1][2]
- Fat content of the lesion
- Hemorrhage
- Calcification or necrosis.[3][4]
Name of Diagnostic Criteria
- There are no established criteria for the diagnosis of angiomyolipoma.
References
- ↑ Sahni VA, Silverman SG (2009). “Biopsy of renal masses: when and why”. Cancer Imaging. 9: 44–55. doi:10.1102/1470-7330.2009.0005. PMC 2739685. PMID 19602467.
- ↑ Wang R, Wood DP (2009). “Evolving role of renal biopsy in small renal masses”. Urol Oncol. 27 (3): 332–4. doi:10.1016/j.urolonc.2008.12.011. PMID 19414125.
- ↑ Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES (2006). “Renal masses in the adult patient: the role of percutaneous biopsy”. Radiology. 240 (1): 6–22. doi:10.1148/radiol.2401050061. PMID 16709793.
- ↑ Schieda N, Kielar AZ, Al Dandan O, McInnes MD, Flood TA (2015). “Ten uncommon and unusual variants of renal angiomyolipoma (AML): radiologic-pathologic correlation”. Clin Radiol. 70 (2): 206–20. doi:10.1016/j.crad.2014.10.001. PMID 25468637.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH